Cook Group Incorporated

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Cook Group Incorporated sits in the top decile of US sponsors by registered trial count (#526 of 15,742 sponsors by registered trial count).

31 total trials none currently recruiting 28 completed later-stage tilt top decile by trial count

Cook Group Incorporated: 31 sponsored US clinical trials, none currently recruiting.

Cook Group Incorporated sponsors 31 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 28 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aorto-iliac Aneurysms, with 2 trials.

Top-decile sponsor footprint

Cook Group Incorporated ranks in the top decile of sponsors by registered trial count (#526 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 66/100

28 of 31 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

31 total, page 1 of 1

COMPLETED

Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas

NCT03321266

COMPLETED NA

Evolution® Biliary Stent System-Fully Covered

NCT02104076

COMPLETED

Evolution® Biliary Stent System Clinical Study

NCT01962168

COMPLETED NA

Removal of the Evolution® Esophageal Stent - Fully Covered

NCT01900691

COMPLETED NA

FORMAT Clinical Study

NCT01804088

COMPLETED

Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair

NCT01784822

COMPLETED

Ligation of the Intersphincteric Fistula Tract (LIFT) + Biodesign for Anal Fistula

NCT01602081

COMPLETED NA

Evaluation of CRB in PROM Patients

NCT01736852

COMPLETED

Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions

NCT01609621

COMPLETED

Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry

NCT01540643

COMPLETED NA

Evaluation of the Cook Biodesign® Nipple Reconstruction Cylinder (NRC)

NCT01216319

TERMINATED NA

Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD)

NCT01199679

COMPLETED NA

PRESERVE-Zenith® Iliac Branch System Clinical Study

NCT01208415

TERMINATED NA

Femoral Micropuncture or Routine Introducer Study

NCT01103141

COMPLETED NA

Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling

NCT00937833

COMPLETED NA

Zenith(R) Low Profile AAA Endovascular Graft Clinical Study

NCT00833924

COMPLETED NA

REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable Stent

NCT00631540

COMPLETED NA

Zenith® Dissection Endovascular System

NCT02094300

COMPLETED NA

Inguinal Hernia Study Using Biodesign IHM

NCT00393887

TERMINATED NA

Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft

NCT00610207

COMPLETED NA

Evaluation of Surgisis Gold Graft for Incision Reinforcement After Open Bariatric Surgery

NCT00274625

COMPLETED Phase 4

Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter

NCT00196118

COMPLETED NA

Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

NCT00120406

COMPLETED NA

Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study

NCT00875563

COMPLETED NA

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

NCT00111176

COMPLETED NA

V-Flex Plus PTX Drug Eluting Coronary Stent

NCT00225693

COMPLETED NA

Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)

NCT00196105

COMPLETED NA

Randomized, Prospective Controlled Trial of Paraesophageal Hernia Repair With Small Intestinal Submucosa (SIS)

NCT00272922

COMPLETED NA

In Stent ELUTES Study

NCT00225680

COMPLETED NA

The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial

NCT00196079

COMPLETED NA

The ELUTES Clinical Trial

NCT00225654

How the Cook Group Incorporated archive is shaped

31 indexed studies, none listed as recruiting (0% open); 28 completed (90%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Aorto-iliac Aneurysms (2 trials), 9 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Cook Group Incorporated: archived-pipeline peers nationwide

Peers matched on 31 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Cook Group Incorporated sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 010203040 0%5%10%15% Total trials Recruiting share Cook Group IncorporatedChildren's Hospitals and Clinics of MinnesotaCytokineticsHalozyme TherapeuticsInsmed Incorporated10xBio22nd Century Group23andMe3-C Institute for Social Development
Cook Group Incorporated sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Cook Group Incorporated sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 31 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Cook Group Incorporated page

31 registered trials is a research-attention snapshot, not an endorsement of Cook Group Incorporated or any single study.

  • None of Cook Group Incorporated's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Aorto-iliac Aneurysms is the condition Cook Group Incorporated studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aorto-iliac Aneurysms trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Cook Group Incorporated pipeline card: 31 registered trials from official public datasets.Report a data error.